Steven Granberg, MD
Interventional Pain Medicine · Saint Louis, MONPI 1881673382
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Boston Scientific at 40.8% of the total. That places this record below the midpoint for interventional pain medicine clinicians in MO, where the typical reported total is $2,673.
Across 14 payments — averaging $23.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$133
- Si-bone, Inc.$98
- Cumberland Pharmaceuticals, Inc.$25
- Abbott$23
- Fidia Pharma USA Inc.$17
- Merz Pharmaceuticals, LLC$16
- plus $14 from 1 others
What the payments were for
- Food & beverage$327100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $133 |
| Si-bone, Inc. | 1 | $98 |
| Cumberland Pharmaceuticals, Inc. | 1 | $25 |
| Abbott | 1 | $23 |
| Fidia Pharma USA Inc. | 1 | $17 |
| Merz Pharmaceuticals, LLC | 1 | $16 |
| AstraZeneca | 1 | $14 |
How this compares
$327 in reported general payments places this provider in the 25th percentile of 27 interventional pain medicine providers in Missouri.
See all interventional pain medicine providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 946 | $29,478 |
| OxycontinOxycodone Hcl | 52 | $24,977 |
| Oxycodone Hcl | 969 | $23,558 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 601 | $21,162 |
| Xtampza ErOxycodone Myristate | 12 | $13,021 |
| Gabapentin | 462 | $8,032 |
| Fentanyl | 66 | $7,539 |
| Tizanidine Hcl | 413 | $5,632 |
| Oxymorphone Hcl ErOxymorphone Hcl | 13 | $5,480 |
| Hydromorphone Hcl | 279 | $5,247 |
| Morphine Sulfate ErMorphine Sulfate | 163 | $4,843 |
| Morphine Sulfate | 103 | $4,129 |
| Cyclobenzaprine Hcl | 400 | $3,884 |
| Pregabalin | 169 | $3,596 |
| Lidocaine | 27 | $2,094 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Saint Louis
- Richard GahnSaint Louis$219
- Ihab IbrahimSaint Louis$159
- Rebecca SandersJoplin$209K
- Ramis GheithBridgeton$73K
- Helen BlakeChesterfield$48K
- Andrew FrazierKansas City$32K
- Christian OliverBridgeton$18K
- David TonkinSpringfield$14K
- Dwayne JonesKansas City$11K
- Bradford NobleColumbia$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.